Abstract: Neutrophil chemotaxis to sites of inflammation is a critical process during normal immune responses to tissue injury and infection and pathological immune responses leading to chronic inflammation. Although progress has been made in understanding the mechanisms that promote neutrophil recruitment to inflamed tissue, the mechanisms that regulate the resolution phase of the inflammatory response have remained relatively elusive. To define the mechanisms that regulate neutrophil-mediated inflammation in vivo, we have developed a novel transgenic zebrafish in which the neutrophils express GFP under control of the myeloperoxidase promoter (zMPO:GFP). Tissue injury induces a robust, inflammatory response, which is characterized by the rapid chemotaxis of neutrophils to the wound site. In vivo time-lapse imaging shows that neutrophils subsequently display directed retrograde chemotaxis back toward the vasculature. These findings implicate retrograde chemotaxis as a novel mechanism that regulates the resolution phase of the inflammatory response. The zMPO:GFP zebrafish provides unique insight into the mechanisms of neutrophil-mediated inflammation and thereby offers opportunities to identify new regulators of the inflammatory response in vivo.
INTRODUCTION
Neutrophil chemotaxis to sites of inflammation is essential during normal immune responses to tissue injury and infection and also contributes to the development of chronic inflammatory diseases such as arthritis and asthma. A better understanding of the mechanisms that regulate leukocyte recruitment and retention in inflamed tissues will provide insight into the pathogenesis of inflammation and will also pave the way for the development of novel therapeutic approaches that dampen or limit the inflammatory response. However, the mechanisms by which inflammation is limited or resolved have remained relatively elusive, to a large extent, as there are few model systems that allow imaging of the inflammatory process in vivo.
The zebrafish, Danio rerio, has emerged as a powerful model organism to study disease mechanisms, as it is amenable to genetic and small molecule screens [1] [2] [3] and has recently been used to study the development of the immune system [4] . Zebrafish embryos develop several immune cells homologous to mammalian counterparts, including lymphocytes, monocyte/ macrophages, and neutrophils [5] [6] [7] . Zebrafish neutrophils can be identified by the expression of the neutrophil-specific protein myeloperoxidase (MPO; also referred to as myeloid-specific peroxidase). Zebrafish MPO (zMPO) mRNA expression can be detected as early as 18 h postfertilization (hpf) within the intermediate cell mass (ICM), a posterior region between the notochord and trunk, and by 3 days postfertilization (dpf), zMPO expression can also be seen in circulating blood cells [8, 9] . The presence of several hematopoietic cell types early in development makes zebrafish embryos an ideal model system to analyze leukocyte migration and inflammatory processes in vivo.
There has been substantial recent interest in understanding the resolution phase of the inflammatory response [10, 11] . Recent reviews suggest that the key mechanism by which neutrophil-mediated inflammation is resolved is by the regulated apoptosis of neutrophils in injured tissue [12, 13] . Here, we provide evidence for an alternative mechanism by which neutrophil-mediated inflammation may be resolved by the retrograde migration of neutrophils from injured tissue back to the vasculature. We have generated a novel transgenic zebrafish that expresses GFP in neutrophils under the control of the zMPO promoter. We have used this transgenic fish to visualize neutrophil-mediated inflammation in vivo and have observed bidirectional neutrophil chemotaxis between sites of tissue injury and the vasculature. This transgenic zebrafish will provide a novel genetic model to further dissect the mechanisms involved in the inflammatory response in vivo.
MATERIALS AND METHODS

Zebrafish maintenance
Adult AB zebrafish (founders purchased originally from the Zebrafish Resource Center, Eugene, OR) and embryos were maintained according to standard protocols [14] and staged as established previously [15] . For wounding assays, zebrafish embryos at 3-4 dpf were anesthetized in E3 containing 0.1 mg/ml Tricaine (ethyl 3-aminobenzoate, Sigma Chemical Co., St. Louis, MO) and then wounded with the tip of a 25-gauge needle. To prevent pigment formation, some embryos (as indicated) were maintained in E3 containing 0.2 mM N-phenylthiourea (PTU; Sigma Chemical Co.).
Endogenous MPO activity assay
Embryos were fixed in 4% paraformaldehyde/PBS for 2 h at room temperature. To detect MPO activity, a Sigma kit (Catalog #390-A) was used as follows: Embryos were washed in1ϫ Trizmal (pH 6.3) containing 0.01% Tween-20 (TT buffer) and then incubated at 37°C in TT containing 1.5 mg/ml substrate (supplied) and 0.015% hydrogen peroxide (from a 30% stock) for 15-30 min. Labeled embryos were then washed in PBS and observed.
Live microscopy of zebrafish embryos
For all movies, embryos were maintained in E3 containing 0.1 mg/ml Tricaine. For Supplemental Movie 1, the embryo was embedded in 1% low-melt agarose, and differential interference contrast (DIC) images were captured (30 s/frame for 3 h) using a Nikon Eclipse TE300 inverted microscope, equipped with a 40ϫ DIC objective (NAϭ0.75), epifluorescent illumination, and a Hamamatsu Orca II charged-coupled device camera. For Supplemental Movie 2, images were captured (10 s/frame for 20 min) using a Nikon SMZ-1500 zoom microscope equipped with epifluorescence and a CoolSnap ES camera (Roper Scientific, Duluth, GA). For Supplemental Movie 3, DIC and fluorescence images were captured (60 s/frame for 4 h) using the same microscope and equipment as for Supplemental Movie 1, except that a 20ϫ DIC objective (NAϭ0.45) was used. All images were captured and analyzed with MetaMorph software; shifts in embryo position were corrected by realigning adjacent images using the "Align" tool, and areas of pigmentation served as markers. Movies were converted to audio video interleave format using MetaMorph and compressed using QuickTime Player Version 7.0.4.
Cloning zMPO promoter and construction of zMPO:GFP plasmid
The BUSM1 P1 artificial chromosome clone (PAC) library (RZPD, Germany) was screened for a PAC containing the zMPO genomic sequence using a 32 P-labeled probe containing the sequence of the zMPO cDNA (Accession #AF349034). A zMPO-positive library clone containing 120 kb was isolated and digested with BglII to release a 10-kb fragment, which was subcloned into pBlueScript SKϩ/Ϫ (Stratagene, La Jolla, CA). This subclone was digested with XhoI and ClaI to release an ϳ8-kb fragment (see Fig. 2A ) of the zMPO 5Ј-untranslated region. A PCR-generated linker comprising the region from the ClaI site to the start of the zMPO open-reading frame (with a BamHI site introduced just upstream) was amplified from the BglII subclone using the following primers: GTGAGCCTGAGACACGCATG (forward) and GCGGATC-CCTCTAAAAACACATATTG (reverse; BamHI site in boldface).
A BamHI/XhoI fragment containing GFP and a SV40 polyadenylation sequence (Clontech, Palo Alto, CA) were ligated with the ClaI/BamHI-digested PCR linker and the 8-kb XhoI/ClaI genomic fragment into XhoI-digested pBlueScript SKϩ/Ϫ, resulting in the zMPO:GFP construct (see Fig. 2B ).
Generation of transgenic zMPO:GFP lines
The zMPO:GFP plasmid was resuspended at 50 pg/nl in Danieau buffer [58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO 4 , 0.6 mM Ca(NO 3 ) 2 , 5.0 mM HEPES, pH 7.6], and 7.5 pg was injected into the cytoplasm of one-cell stage embryos, which were raised to sexual maturity and crossed to wild-type zebrafish to produce F1 embryos that were screened for cellular GFP expression in the ICM at 2-3 dpf.
Antibody production
The zMPO open-reading frame was PCR-amplified from a zMPO cDNA (Accession #AF349034 in pBK-CMV) using the following primers: AGAAC-TAGTCGACAGTGTTGTGCTCTTTCAGTGG (forward; SalI site in boldface) and ATAAGTAAGCGGCCGCAACATCCCTGAGGTTTGGTTATA (reverse; NotI site in boldface). This PCR product was digested with SalI and NotI and subcloned into SalI/NotI-digested pGEX-4T-1 (Amersham, UK) to produce pGST-zMPO, and the GST-zMPO fusion protein expressed from this plasmid was purified and used to raise a rabbit polyclonal antibody as described previously [16] .
Whole-mount immunofluorescence
Embryos were fixed for 2 h in 1% formaldehyde (Electron Microscopy Sciences, Hatfield, PA) in PBS and washed in PBS and then PBS containing 0.15 M glycine (Sigma Chemical Co.). Emrbyos were next washed in methanol at -20°C and rehydrated in a graded series of methanol in PBS containing 0.2% Triton X-100 (PBS-TX). Embryos were blocked in PBS-TX containing 1% (w/v) BSA and incubated overnight at 4°C in the rabbit polyclonal antibody to zMPO (described above) diluted in blocking medium. Following several washes in PBS-TX, embryos were incubated for 3-4 h in a tetramethylrhodamine isothiocyanate-conjugated goat anti-rabbit antibody (Jackson ImmunoResearch Laboratories, West Grove, PA) diluted in blocking medium. Embryos were washed in a graded series of glycerol in PBS-TX, the last wash containing 1 mg/ml 1,4-diazabicyclo-[2.2.2]octane (Sigma Chemical Co.) as an anti-photo-bleaching agent. Fluorescence in immunolabeled embryos was observed using a Nikon SMZ-1500 zoom microscope or a Nikon Eclipse TE300 inverted microscope and imaged with MetaMorph software.
To immunolabel transgenic zMPO:GFP embryos, the same protocol was used with the following modifications to preserve GFP fluorescence: Embryos were fixed in 6% paraformaldehyde/PBS for 2 h at room temperature and then overnight at 4°C in 4% paraformaldehyde/PBS. Following fixation, embryos were washed in PBS, then PBS-TX, and then TBS (150 mM NaCl, 15 mM Tris, pH 7.4) containing 0.01% Tween-20 (TBST). To quench background autofluorescence, embryos were treated twice with sodium borohydride (Sigma Chemical Co., 1 mg/ml in TBST) for 15 min with periodic inversion. Methanol washes (and subsequent rehydration) were omitted, as this was observed to remove GFP fluorescence.
Flow cytometry of adult zebrafish hematopoietic cells
Hematopoietic cell isolation (blood and whole kidney marrow) and flow cytometry were performed as described previously [17, 18] using a FacsScan single laser (488 nM argon ion) bench-top cytometer. Note that heparin (American Pharmaceutical Partners, Schaumburg, IL) was added to media (at 10 units/ml) used for live cells. GFP-positive cells were determined according to viability (propidium iodide exclusion), autofluorescence (i.e., lacking red fluorescence), and green fluorescence expression. Flow cytometry data were analyzed using FloJo software (TreeStar, Inc., Ashland, OR). Data (see 
Cell tracking and cell speed measurement
Individual cells (nϭ25 neutrophils, nϭ11 low GFP-expressing cells described in the text) were tracked using the "Track point" function of MetaMorph and average cell speeds calculated as described previously [19] . Each cell was tracked as long as it could be distinguished from other migrating cells. Cell tracks were generated using MS Excel and overlaid onto individual images from movies (see Fig. 6 ). To calculate velocity and persistence of migration directionality (see Fig. 7 ), cell centroid positions of zebrafish neutrophils were tracked toward the wound (nϭ20) and toward the vasculature (nϭ20) using the Track point function of MetaMorph. Directionality index (D/T) was calculated by determining the shortest linear distance (D) between the start point and end point of the migration path compared with the total distance traveled by the cell (T) as described previously [20] . The higher the D/T (0.7-1.0) indicates highly directional migration and a loss of random motility.
RESULTS
Leukocyte recruitment in response to tissue injury in zebrafish embryos
Previous studies have demonstrated that neutrophil-mediated inflammation can be induced in zebrafish embryos by tissue injury. These studies have shown that transection of the tail induces the recruitment of cells that are positive for neutrophilspecific MPO activity and express zMPO mRNA [8] . In accordance with these findings, we performed time-lapse microscopy of zebrafish embryo (3-4 dpf) fins after being wounded (Supplementary Movie 1) and observed the robust recruitment of leukocytes to the site of tissue injury. To quantify this response, wounds were induced in the tailfins of zebrafish embryos (at 4 dpf), and the neutrophil response to wounding was studied in fixed embryos by assaying for MPO activity at different times after wounding. We observed increasing numbers of MPO-positive cells at wound sites up to 6 h postinjury, after which, we consistently observed a decrease in these numbers down to the apparent resolution of the response by 24 h post-injury (Fig. 1) . To address the mechanism by which this inflammatory response is resolved, we developed a transgenic zebrafish that expresses GFP under the control of the zMPO promoter to enable high-resolution analysis of neutrophil-mediated inflammation in vivo.
Development of a zMPO:GFP transgenic zebrafish
To generate a transgenic zebrafish that expresses GFP in neutrophils, ϳ8.0 kB of the 5Ј-untranslated region of the zMPO gene was cloned upstream of GFP (Fig. 2, A and B) . This plasmid construct was microinjected into wild-type zebrafish embryos and shown to transiently express GFP by 22 hpf in distinct cells over the anterior yolk sac and ICM (Fig.  2C ). Embryos injected with this construct were raised to ma- Fig. 1 . Quantification of neutrophil recruitment in response to wounding. Zebrafish embryos at 4 dpf were wounded in the tailfin and allowed to recover for the indicated times (x-axis). At each time-point, ϳ25 embryos were fixed and assayed for MPO activity; the inset box shows an example of a tailfin that was wounded (*) and labeled using the MPO activity assay. The number of MPO-positive cells (examples marked with arrows) responding to each wound was counted and averaged (y-axis; error bars indicate SEM) for each time-point. Note that there were consistently no MPO-positive cells in the tailfins of embryos fixed immediately after wounding. Fig. 1 ) and confirmed to exhibit a distribution consistent with zMPO mRNA [8, 9] . It is notable that at 3 dpf, GFP expression was observed in cells around the head and heart (Fig. 2D ) and within the ICM (Fig. 2E) . To confirm that GFP is expressed in cells that also express zMPO, we developed an antibody to the zMPO protein that labels cells in a similar pattern to zMPO mRNA (Fig. 2F) . Cross-reactivity with GFP-expressing cells in zMPO:GFP transgenic embryos was observed in the ICM and at wound sites (Fig. 2, G-I) , confirming that the transgenic construct is expressed in cells that also express zMPO. There was also some expression in apparent nonhematopoietic and nonmotile cells (Supplemental Fig. 1; Fig. 2E ), which did not label with the zMPO antibody (Fig. 2F) and did not interfere with imaging of zebrafish neutrophils. Together, these findings demonstrate that we have successfully generated a transgenic zebrafish that expresses GFP in embryonic zebrafish neutrophils.
To confirm the neutrophil-specific expression of the zMPO: GFP transgene in adult zebrafish, hematopoietic cells from circulating blood and whole kidney marrow were isolated from transgenic zebrafish and analyzed by flow cytometry. Previous studies have demonstrated that zebrafish hematopoietic cells can be sorted into four groups based on light-scattering characteristics: erythrocyte, lymphocyte/thrombocyte, granulocyte/ monocyte, and precursor fractions [17, 18] . Another study has shown that MPO activity can be detected during multiple stages of adult neutrophil development [8] , reaching its highest level during precursor stages prior to reaching maturity. Consistent with these results, GFP-positive cells from the principal site of adult blood cell development, whole kidney marrow, were found to cluster predominantly in the precursor and granulocyte/monocyte fractions (Fig. 3B) . In contrast, GFPpositive cells from circulating blood, where mainly mature blood cells are present, clustered mainly in the granulocyte/ monocyte fraction (Fig. 3D) . These results confirm further that we have generated a transgenic line which expresses GFP in neutrophils, and we therefore used the transgenic fish to study neutrophil migration in vivo.
In vivo imaging of neutrophil motility in zMPO: GFP transgenic embryos
To observe neutrophil motility in the zMPO:GFP transgenic embryos, live time-lapse fluorescence microscopy of embryos at 3 dpf was performed. In addition to neutrophils circulating through the vasculature, spontaneous neutrophil motility was observed in the head (data not shown), within bodily tissues (Fig. 4) , and within the ICM (Supplementary Movie 2) .
To observe neutrophil chemotaxis in vivo, zMPO:GFP embryos were wounded in the fin at 3 dpf (Supplemental Movie 3). Wounding induced the robust recruitment of neutrophils to the wound site (Fig. 5, top) with a range of behaviors and morphologies. During migration, these cells take on a highly polarized morphology, exhibiting a broad, leading edge or pseudopod and a narrow cell rear (Fig. 6A) . Pseudopod extension and abrupt changes in the direction of migration were frequently observed (Fig. 6C) . After migration to the wound site, some neutrophils stop and arrest at the wound, where they develop a rounded morphology and reduced pseudopod extension (Fig. 6B) . Other neutrophils continued migration within or around the wound (Fig. 6C) . The average speed of migration of zebrafish neutrophils (taken from nϭ25 complete cell tracks) Fig. 3 . Flow cytometry of hematopoietic cells from adult transgenic zMPO:GFP zebrafish. Forward-scatter (FSC) and side-scatter (SSC) data were obtained for whole kidney marrow (A) and blood (C) and gates drawn according to cell type based on previous studies [17, 18] . GFPϩ cells (determined as detailed in Materials and Methods) from whole kidney marrow (B) and blood (D) were replotted according to FSC and SSC and analyzed using the gates drawn in A and C. For each fraction, the percentage of the total number of cells on the graph is indicated next to each gate. was 9.94 Ϯ 0.36 m/min, which is comparable with the in vitro motility observed for human neutrophils [19] . A slowermoving (3.50 Ϯ 0.50 m/min) cell type, which faintly expresses GFP, was also observed to migrate toward wound sites (Fig. 5, arrowheads) . These cells exhibited an elongated morphology distinct from neutrophils and usually arrived at a wound site after the first-arriving neutrophils. Based on these characteristics and previous observations [21] , we anticipate that these cells may represent a subpopulation of the monocyte/ macrophage lineage [22] , which has been shown to exhibit a low level of MPO activity [23] .
Zebrafish neutrophils demonstrate retrograde chemotaxis toward the vasculature
To address the resolution phase of the inflammatory response, neutrophil trafficking was observed for extended times after wounding. It is interesting that zebrafish neutrophils displayed retrograde chemotaxis from the wound site back toward the vasculature (Figs. 5, bottom, and 6, B-D) , implicating retrograde migration as a mechanism involved in resolving the inflammatory response. We observed no apparent apoptosis of neutrophils at wound sites during the course of any time-lapse movie, even in those with a significant (up to ϳ10 cells) and prolonged inflammatory response (data not shown). Rather, the majority of cells that entered the wound (more than 80%) was observed to track back toward the vasculature, the remainder of which were usually still migrating around wound sites at the end of individual movies. To quantify the migration and to determine the significance of the retrograde chemotaxis, migration velocity and directionality were calculated from tracks of neutrophils migrating toward (Fig. 7A) or away from (Fig.  7B ) fin wounds. Directionality can be calculated by determining the ratio of the shortest linear distance traveled compared with the total distance traveled (D/T), as described in Materials and Methods. It is interesting that the velocity and directionality were comparable for neutrophils traveling toward the wound and back toward the vasculature (Fig. 7C) . Furthermore, the majority of directionality measurements indicated that the migration tracks were highly directional (average D/Tϭ0.7) and not the result of random motility. These observations indicate that the retrograde chemotaxis back toward the vasculature is an active process, comparable with the motility response directed toward the wound.
Further analysis of neutrophil motility in response to wounding indicated that different neutrophils were observed to display simultaneous, bidirectional migration (Supplemental Movie 3). This suggests that after stopping at a wound, individual neutrophils gain the ability to respond to signals other than those generated from the wound site, rather than having a global cessation of the wound signal that limits neutrophil recruitment at a specific time. Together, our findings suggest that retrograde migration away from wound sites may constitute a mechanism by which neutrophilic inflammation is resolved.
DISCUSSION
We have generated a novel transgenic zebrafish in which neutrophil chemotaxis and inflammatory responses can be visualized with high resolution in vivo. This system provides a genetically tractable model of zebrafish inflammatory responses and also represents a powerful tool to dissect mechanisms that modulate neutrophil polarization and chemotaxis in vivo. Using this model, we have identified a unique mechanism of neutrophil trafficking between sites of tissue injury and the vasculature.
The mechanisms that resolve inflammation have remained elusive because of the limited tools available to image inflammation in vivo. Recent reviews [11, 13] have indicated that neutrophil-mediated inflammation is resolved by regulated apoptosis of neutrophils in inflamed tissue. In contrast, our findings indicate that neutrophils traffick bidirectionally between sites of tissue injury and the vasculature, suggesting that retrograde neutrophil chemotaxis to the vasculature may provide a novel and important mechanism by which inflammation is resolved. It is interesting that our findings demonstrate that Images from a time-lapse movie of the midbody of a zMPO:GFP embryo at 3 dpf. At the top is an oblique coherent contrast image corresponding to the first frame of the movie; below are fluorescence images captured at the times indicated. The arrow indicates a single GFPϩ cell that migrates across the midbody, apparently outside of the vasculature, over an ϳ20-min period. leukocyte velocity and directionality are the same to and from the wound, indicating that the retrograde chemotaxis is an active process and is not the result of random motility. There has been speculation of this "round-trip" migration by neutrophils and other leukocytes [24] , and we now provide direct evidence to support this model. Our findings are in accordance with a recent report that indicates that neutrophils can undergo retrograde migration across the endothelium after transendothelial migration [25] . Taken together, these studies and our observations suggest that retrograde chemotaxis may complement regulated neutrophil apoptosis to resolve inflammation. To study this possibility further, we are developing zebrafish models of chronic inflammation induced by genetic mutations (J. R. Mathias, unpublished observations) or bacterial infections as previously reported [26, 27] .
A challenge for future investigation will be to determine the factors that modulate bidirectional motility and to further dissect how a neutrophil prioritizes these competing signals in vivo. It is interesting that we detected simultaneous, bidirectional trafficking between the wound and vasculature, suggesting that neutrophils are able to migrate back to the vasculature in the presence of active, migration-inducing signals at the wound. Although we are not certain of the signals that regulate this process, it appears that neutrophils responding to a wound are prioritizing opposing signals from the wound and the vasculature. Recent studies have shown that chemoattractant signals can also induce retrograde chemotaxis ("fugetaxis") away from high concentrations of the signal [28] . It is possible that conditions may be present in the immediate vicinity of a wound site, which induces fugetaxis. Chemokine communication from other later-arriving blood cells may also induce retrograde movement of neutrophils, which have been shown to interact with other blood cells through secreted signals [29] and cellto-cell contacts [30] .
Our findings suggest that mutations or exogenous agents that affect neutrophil chemotaxis may lead to neutrophil retention and chronic inflammation. Accordingly, we recently reported that a patient with the chronic inflammatory disease, neonatal onset multisystem inflammatory disease, and a mutation in cryopyrin displayed reduced neutrophil chemotaxis in vitro [31] . It is possible that this reduced capacity for chemotaxis may have contributed to chronic neutrophilic inflammation by reducing the resolution phase by retrograde chemotaxis. Our findings also demonstrate that zebrafish neutrophils often arrest at wound sites prior to trafficking back to the vasculature (Fig.  6B) , exhibiting a rounded morphology and loss of pseudopod extension similar to observations of arrested lymphocytes in vivo [32] . This suggests that loss of "stop" signals may be a key switch involved in resolving inflammation and that if improperly regulated, may result in the retention of neutrophils within an inflamed area. In recent in vitro studies, we provide evidence that TNF-␣ may provide such a stop signal to human neutrophils and reduce sensitivity to other chemotactic stimuli [33] .
In addition to providing key insight into how neutrophils traffick and contribute to inflammation, this transgenic zebrafish provides a novel tool to identify the mechanism of action of anti-inflammatory agents and is amenable to highthroughput screening of small molecule compounds that may aid in the identification of novel therapeutic agents [1] . A recent study accentuates the potential of this system, as chemotaxis of embryonic zebrafish macrophages was disrupted by treatment with the microtubule-destabilizing drug nocodazole [34] . In addition, the random motility of zebrafish neutrophils through bodily tissues (Fig. 4 and Supplemental Movie 2), which we observed, can potentially be used as an indicator of neutrophil viability in response to drug treatments or to specifically identify agents that affect neutrophil chemotaxis without affecting random motility in vivo.
In summary, we have developed a novel technology that will provide a powerful tool for understanding inflammation in vivo and can be used for genetic or chemical screens. The identification of signaling pathways that modulate these specific stages of the inflammatory response may provide key insight into novel therapeutic targets that may be used to limit the inflammatory response. The further analysis of neutrophil trafficking in the context of chronic inflammatory zebrafish models will also provide important insight into how these mechanisms may go awry and contribute to chronic inflammation.
